Hematology

Immunogenomic Landscape of Hematological Malignancies Mapped
The reaction of the body's immune system against cancer can be thought of as a cycle. Cancer cells contain proteins that differ from proteins in other tissue. Their components, known as antigens, have to be presented to the T cells of the immune system by the cancer cells. More...20 Jul 2020

Clonal Hematopoiesis of Indeterminate Potential Associated with hsC-Reactive Protein
Clonal hematopoiesis (CH) occurring in normally aging subjects, initially suggested by X-chromosome inactivation studies, is caused by acquired mutations in genes recurrently mutated in hematological cancers, and in non-driver candidates. More...14 Jul 2020

Novel Device Compared to Thromboelastography for Clotting Defects
Clotting disorders occur when the body is unable to make sufficient amounts of the proteins that are needed to help the blood clot, stopping bleeding. These proteins are called clotting factors (coagulation factors). All clotting factors are made in the liver which requires vitamin K to make some of the clotting factors. More...09 Jul 2020
Diagnostic Assay Developed for Unclassified Severe Combined Immune Deficiency
Severe combined immune deficiency (SCID) is a group of rare hereditary genetic disorders, and is characterized by a total absence of immune system function, including an absence of T-lymphocytes, the white blood cells that play a crucial role in the body's immune defense. More...30 Jun 2020

Detection Rate of Monoclonal Gammopathy of Undetermined Significance Determined
Multiple myeloma (MM) is a clonal plasma cell malignancy that accounts for approximately 2% of all malignancies. Plasma cells help you fight infections by making antibodies that recognize and attack pathogens. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they displace healthy blood cells. More...30 Jun 2020

Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive hematopoietic stem cell malignancy that is characterized by the clonal proliferation of myeloid precursors. Abnormal accumulation of leukemic blasts in the bone marrow, blood, and other tissues results in significant reductions of normal blood cells. More...25 Jun 2020

In Other News
Cord Blood Transplants May Outperform Matched Sibling Donors
Thromboelastography Identifies Undetected Blood Clots in COVID-19 Patients
Streamlined Assay Improves Prenatal Detection of Alpha-Thalassemia
Biomarkers Evaluated in Children with Community-Acquired Pneumonia
Smartphone-Based Technique Helps Doctors Assess Hematological Disorders
Soluble Transferrin Receptor Investigated in Iron Deficiency Anemia
Microcytosis Is a Risk Marker of Cancer in Primary Care
Lupus Anticoagulant Prolongs Activated Partial-Thromboplastin Time in COVID-19
Immune Microenvironment Changes Contribute to Early-Stage Multiple Myeloma
Blood Clotting Causes Significant Mortality in COVID-19 Patients
Physiological Mechanisms Underlying Prevalent Pediatric Leukemia Discovered
Human NK Cells Identified by Single-Cell RNA Sequencing
Functional Comparison of Different Tubes for Isolating Mononuclear Cells
Complete Blood Count Predicts Asymptomatic Preterm Birth
sTNFR2 Revealed as a Novel Diagnostic Biomarker for Acute ATL
Molecule in Lymphatic System Implicated in Autoimmune Diseases
Factors Associated with ARDS in COVID-19 Identified
Prognostic Values of Platelet Parameters in Gynecological Tumors Patients
Fibrinogen-Albumin Ratio Correlated to Ankylosing Spondylitis Disease Activity
NGS Identifies Genomic Characteristics of Pediatric Leukemia
Minimal Residual Disease Assessed in AL Amyloidosis Patients
Microbiome Composition Predicts Outcome Among Stem Cell Transplant Patients
Predictors Evaluated for Microalbuminuria in Type 2 Diabetes
The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.








